Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AnaptysBio, Inc. (ANAB : NSDQ)
 
 • Company Description   
AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Number of Employees: 104

 
 • Price / Volume Information   
Yesterday's Closing Price: $48.73 Daily Weekly Monthly
20 Day Moving Average: 582,829 shares
Shares Outstanding: 29.90 (millions)
Market Capitalization: $1,456.78 (millions)
Beta: 0.76
52 Week High: $72.36
52 Week Low: $20.49
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.74% -4.75%
12 Week -11.46% -13.63%
Year To Date 0.52% -11.37%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10770 WATERIDGE CIRCLE SUITE 210
-
SAN DIEGO,CA 92121
USA		 ph: 858-362-6295
fax: -		 investors@anaptysbio.com http://www.anaptysbio.com
 
 • General Corporate Information   
Officers
Daniel Faga - President; Chief Executive Officer and Director
Dennis Mulroy - Chief Financial Officer
Dennis Fenton - Director
Rita Jain - Director
Magda Marquet - Director

Peer Information
AnaptysBio, Inc. (CORR.)
AnaptysBio, Inc. (RSPI)
AnaptysBio, Inc. (CGXP)
AnaptysBio, Inc. (BGEN)
AnaptysBio, Inc. (GTBP)
AnaptysBio, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 032724106
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/03/26
Share - Related Items
Shares Outstanding: 29.90
Most Recent Split Date: (:1)
Beta: 0.76
Market Capitalization: $1,456.78 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.52 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.30 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 324.87
PEG Ratio: -
Price Ratios
Price/Book: 111.25
Price/Cash Flow: -
Price / Sales: 6.13
EPS Growth
vs. Year Ago Period: 91.79%
vs. Previous Quarter: 94.02%
Sales Growth
vs. Year Ago Period: 23.47%
vs. Previous Quarter: 7.56%
ROE
09/30/26 - -
06/30/26 - 112.00
03/31/26 - -
ROA
09/30/26 - -
06/30/26 - 2.20
03/31/26 - -7.75
Current Ratio
09/30/26 - -
06/30/26 - -
03/31/26 - 7.58
Quick Ratio
09/30/26 - -
06/30/26 - -
03/31/26 - 7.58
Operating Margin
09/30/26 - -
06/30/26 - 3.23
03/31/26 - -11.53
Net Margin
09/30/26 - -
06/30/26 - 82.37
03/31/26 - -11.53
Pre-Tax Margin
09/30/26 - -
06/30/26 - -
03/31/26 - -11.46
Book Value
09/30/26 - -
06/30/26 - -
03/31/26 - 0.44
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - -
Debt-to-Equity
09/30/26 - -
06/30/26 - -
03/31/26 - 0.00
Debt-to-Capital
09/30/26 - -
06/30/26 - -
03/31/26 - 0.00
 

Powered by Zacks Investment Research ©